Please login to the form below

Not currently logged in
Email:
Password:

Shire launches ADHD and You educational website

Resource designed for patients, carers and HCPs

Shire, ADHD educational programme

Shire US has launched a US-focused educational programme for people with attention-deficit/hyperactivity disorder (ADHD), their families and healthcare professionals (HCPs).

The ADHD: A Shared Focus programme was developed by Shire Patient Advocacy Specialists and will be delivered through multiple channels, including print and online.

The website, ADHD & You, features information about the condition, its diagnosis, as well as recommended components for an ADHD management plan and provides decided sections for patients, carers and healthcare professionals.

“Through the work Shire has done in the field of ADHD to support patients, caregivers, and health care professionals, we have gained a tremendous depth of knowledge about ADHD,” said Michael Yasick, senior vice president of Shire's Behavioral Health Business Unit.

“As a result, we identified a need for more resources for people impacted by ADHD and those who care for them.

“The goal of these resources is to encourage dialogue between people with ADHD, their caregivers and health care professionals,” Yasick said.

Shire has a portfolio of ADHD drugs and a history of ADHD patient support, which has seen it back a Europe-wide campaign to drive awareness of the condition in schools and the establishing of a scholarship programme for US ADHD students.

17th January 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics